Study of β-lactam resistance in ceftazidime-resistant clinical isolates of Enterobacteriaceae
- 21 May 1998
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 10 (2) , 135-141
- https://doi.org/10.1016/s0924-8579(98)00027-2
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Survey of prevalence of extended spectrum β-lactamases among EnterobacteriaceaeJournal of Antimicrobial Chemotherapy, 1996
- Is it important to identify extended-spectrum beta-lactamase-producing isolates?European Journal of Clinical Microbiology & Infectious Diseases, 1996
- CeftazidimeDrugs, 1995
- TEM- and SHV-derived extended-spectrum β-lactamases: relationship between selection, structure and functionJournal of Antimicrobial Chemotherapy, 1995
- Plasmid-mediated production of Class I (AmpC) β-lactamase by two Klebsiella pneumoniae isolates from the UKJournal of Antimicrobial Chemotherapy, 1995
- Ceftazidime Resistance Among Selected Nosocomial Gram-Negative Bacilli In The United StatesThe Journal of Infectious Diseases, 1994
- Identification of a novel plasmid-mediated β-lactamase with chromosomal cephalosporinase characteristics from Klebsiella pneumoniaeJournal of Antimicrobial Chemotherapy, 1993
- Characterization of the plasmid mediated β-lactamase BIL-1Journal of Antimicrobial Chemotherapy, 1992
- Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 1990
- Contribution of Chromosomal β-Lactamases to β-Lactam Resistance in EnterobacteriaClinical Infectious Diseases, 1986